Roche Diagnostics will consolidated instrument manufacturing in a new 60,000-square-foot building on West Tangerine Road, about 18 miles north of Tucson.
David Wichner Roche Tissue Diagnostics will soon have more space to boost production of its cancer-detecting instruments and tests after cutting the ribbon on a new, 60,000-square-foot building in Marana on Monday.
About 140 manufacturing workers out of its current workforce of about 1,800 at its main campus at Oro Valley’s Innovation Park, about 14 miles east of the Marana site, will move to the new Marana building by the end of January, Roche said. She noted that 14 million patients are diagnosed with cancer annually worldwide, and the company’s diagnostics support some 26 million patients.
Construction on the new building began in May 2021. Roche acquired the finished factory building for $19 million from Institutional Property Advisors, part of Marcus & Millichap.In May, Roche unveiled the Employee Forum, a two-story, 45,000-square-foot building at the Oro Valley site that features a conference center, an expansive cafeteria, a gym, wellness center and meeting rooms.
Contact senior reporter David Wichner at [email protected] or 520-573-4181. On Twitter: @dwichner. On Facebook: Facebook.com/DailyStarBiz
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Houston nonprofit Bread of Life, Quest partner to improve health care access, conbat food insecurityHouston nonprofit Bread of Life, Quest partner to improve health care access, combat food insecurity
Leer más »
Alzheimer’s Drug From Roche Fails in Late-Stage TrialsThe disappointing results come weeks after a similar treatment developed by two competitors delivered promising data, infusing fresh hope into a field that has been marked by a string of failures.
Leer más »
Breakingviews - Roche reminds investors big drug bets have risksShareholders in Swiss drug giant Roche are learning the downside of making big bets on new drugs. On Monday, the $266 billion Basel-based pharma giant revealed disappointing test results for its new dementia treatment. The drug, known as Gantenerumab, was not shown to preserve abilities such as remembering, solving problems, orientation and personal care in patients suffering from early stages of Alzheimer’s disease. Rival Biogen had scored a hit with a similar drug in September.
Leer más »
Leicester beat West Ham 2-0 after Maddison injury scareLeicester City beat West Ham United 2-0 with goals from James Maddison and Harvey Barnes on Saturday to complete a hat-trick of away wins in the Premier League, though Maddison gave England fans a brief scare when he went off for treatment.
Leer más »
Dave Chappelle’s ‘SNL’ Opening Monologue Addresses Kanye “Ye” West, Kyrie Irving’s Antisemitic CommentsThe comedian also tackled Donald Trump and midterm elections.
Leer más »